Regen BioPharma, Inc.

8-K Entered a material agreement; Changed accountants; Other events Jul 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Unregistered sale of equity Mar 4, 2026 10-Q Quarter ended 2025-12-31 Feb 13, 2026 8-K Unregistered sale of equity Feb 2, 2026 8-K Other events Jan 21, 2026 10-K Fiscal year ended 2025-09-30 Dec 30, 2025 8-K Unregistered sale of equity Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 3, 2025 8-K Unregistered sale of equity Sep 19, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 7, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 1, 2025 8-K Unregistered sale of equity Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 28, 2025 10-Q Quarter ended 2024-12-31 May 16, 2025 10-K Fiscal year ended 2024-09-30 May 13, 2025 8-K Previously issued financials not reliable May 13, 2025 8-K Changed accountants Apr 7, 2025 8-K Results of operations (earnings release) Nov 29, 2024 8-K Other events Sep 18, 2024 8-K Entered a material agreement Sep 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Changed accountants May 29, 2024 8-K Amended charter or bylaws; Other events May 23, 2024 8-K Changed accountants May 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 29, 2024 10-Q Quarter ended 2024-03-31 Apr 24, 2024 8-K Other events Feb 9, 2024 10-Q Quarter ended 2023-12-31 Jan 19, 2024 10-K Fiscal year ended 2023-09-30 Nov 20, 2023 8-K Entered a material agreement Sep 18, 2023 10-Q Quarter ended 2023-06-30 Jul 25, 2023 10-Q Quarter ended 2023-03-31 Apr 18, 2023 8-K Unregistered sale of equity; Modified rights of security holders Mar 21, 2023 8-K Amended charter or bylaws Feb 7, 2023 10-Q Quarter ended 2022-12-31 Jan 19, 2023 8-K Unregistered sale of equity Nov 21, 2022 8-K Unregistered sale of equity Nov 18, 2022 10-K Fiscal year ended 2022-09-30 Nov 15, 2022